Alnylam Pharmaceuticals (NasdaqGS:ALNY) FY Conference January 12, 2026 12:00 PM ET Company ParticipantsYvonne Greenstreet - CEOTolga Tanguler - Chief Commercial OfficerPushkal Garg - Chief Research and Development OfficerJeff Poulton - CFOConference Call ParticipantsJessica Fye - Managing Director and Senior Biotechnology AnalystJessica FyeGood morning, everyone. My name's Jess Fye, biotech analyst at JPMorgan, and we're continuing the 44th annual JPMorgan Healthcare Conference this morning with Alnylam. Th ...

Bruker (NasdaqGS:BRKR) FY Conference January 12, 2026 12:00 PM ET Company ParticipantsFrank Laukien - CEOMark Munch - EVPGerald Herman - CFOConference Call ParticipantsCasey Woodring - AnalystCasey WoodringGood evening. This is Casey Woodring from the Life Science Tools and Diagnostics team. Pleased to be joined by the management team of Bruker. This is a standard 40-minute session. We'll do a corporate presentation and then Q&A afterwards. Frank, take it away.Frank LaukienGood morning, everybody. Thank you ...

CeriBell (NasdaqGS:CBLL) FY Conference January 12, 2026 12:00 PM ET Company ParticipantsJane Chao - CEOConference Call ParticipantsRobbie Marcus - AnalystRobbie MarcusGood morning, everyone. I'm Robbie Marcus, the MedTech analyst at JPMorgan. Very happy to introduce our next company, Ceribell. We'll have Jane Chao, the CEO, come up for a presentation, followed by some Q&A. Jane?Jane ChaoThank you, Robbie. Good morning, everyone. I'm very excited to share with you the overview of Ceribell and our 2025 accomp ...

Xenon Pharmaceuticals (NasdaqGM:XENE) FY Conference January 12, 2026 12:00 PM ET Company ParticipantsIan Mortimer - President and CEOChristopher Kenney - CMOConference Call ParticipantsTessa Romero - Senior Biotech AnalystTessa RomeroWelcome, everyone, to the 44th Annual J.P. Morgan Healthcare Conference. My name is Tess Romero, and I'm one of the Senior Biotech Analysts here at J.P. Morgan. Our next presenting company is Xenon Pharmaceuticals, and presenting on behalf of the company, we have President and ...

Cencora (NYSE:COR) FY Conference January 12, 2026 12:00 PM ET Company ParticipantsJames Cleary - CFOLisa Gill - Head of Healthcare ServicesRobert Mauch - CEOLisa GillGood morning, and thank you for joining us. My name is Lisa Gill, and I head up Healthcare Services at J.P. Morgan. It is with great pleasure this morning that we have with us Cencora. Presenting for Cencora will be CEO Bob Mauch. In addition, we have Jim Cleary, a CFO, who will join me for the Q&A session. With that, I'm going to turn it over ...

Novartis (NYSE:NVS) FY Conference January 12, 2026 12:00 PM ET Company ParticipantsVasant Narasimhan - CEOAngus Liu - JournalistConference Call ParticipantsRichard Vosser - European Pharma AnalystRichard VosserWelcome to the 44th J.P. Morgan Healthcare Conference. I'm Richard Vosser, European Pharma Analyst at J.P. Morgan. It's my great pleasure to host the CEO of Novartis, Vasant Narasimhan, for this presentation. Just a housekeeping: if you have a question, you can either raise your hand or you can go thr ...

Telix Pharmaceuticals (NasdaqGS:TLX) FY Conference January 12, 2026 12:00 PM ET Company ParticipantsChristian Behrenbruch - CEOConference Call ParticipantsChris Cooper - AnalystNone - AnalystChris CooperWe'll have some important FDA meetings.Christian BehrenbruchOkay.Chris CooperOkay, good morning. Thanks for joining us here at the J.P. Morgan Healthcare Conference. My name is Chris Cooper. I cover Australian healthcare here at J.P. Morgan. For this session, we're very fortunate to be joined by Christian Be ...

PTC Therapeutics (NasdaqGS:PTCT) FY Conference January 12, 2026 12:00 PM ET Company ParticipantsRoss Taylor - CFOOguzhan Atay - Co-founder and CEOMatthew B. Klein - CEOConference Call ParticipantsBrian Cheng - Senior Biotech AnalystCasey Woodring - AnalystBrian ChengGood morning, everyone. Thanks for joining us for another session at the 44th J.P. Morgan Healthcare Conference. I'm Brian Cheng, one of the senior biotech analysts here at the firm. At the podium, we have the CEO of PTC Therapeutics, Matt Klein ...

Johnson & Johnson (NYSE:JNJ) FY Conference January 12, 2026 11:15 AM ET Company ParticipantsJoaquin Duato - Chairman and CEOChris Schott - Managing Director and Senior Equity Research AnalysChris SchottGood morning. I'm Chris Schott from JPMorgan, and it's my pleasure to be hosting this fireside discussion with Joaquin Duato, the Chairman and CEO of J&J. Joaquin, happy New Year.Joaquin DuatoThank you.Chris SchottGreat speaking with you today. Do you want to just open up the conversation? We're coming off of ...

iRhythm Technologies (NasdaqGS:IRTC) FY Conference January 12, 2026 11:15 AM ET Company ParticipantsQuentin Blackford - President and CEODan Wilson - CFOConference Call ParticipantsAllen Gong - VP and Equity Research AnalystAllen GongOkay, thanks everyone for coming today. My name's Allen Gong here on the JPMorgan MedTech team. I'm really excited to have the management team of iRhythm here today this morning. We're going to start off with some prepared remarks from CEO Quentin Blackford, and then we're goin ...